Akumin Inc. has filed an amendment to its preliminary prospectus in connection with its proposed initial public offering (IPO) by way of qualifying common shares issuable upon the exercise of previously issued or converted special warrants and broker warrants.
The amendment included 565,563 common shares issuable upon exercise of 533,550 special warrants and 32,013 broker warrants.
On November 15, 2017, Akumin issued 533,550 special warrants for gross proceeds of $1,867,425 and issued 32,013 broker warrants in connection with the financing.
Clarus Securities Inc. acted as the sole agent for the offering. Stikeman Elliott LLP acted as legal counsel to Akumin and Borden Ladner Gervais LLP acted as counsel to the agent.
Akumin is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States, with 71 centers that are: wholly-owned (58), partly-owned (11) or managed (2), located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas (as of September 30, 2017)
Akumin’s services include magnetic resonance imaging (MRI), x-ray, ultrasound and computed tomography (CT) scans, among other diagnostic radiology services. Its network of independently-owned radiology centers is dedicated to improving the overall experience of care, with a specific focus on providing the right diagnostic imaging to unlock the right diagnosis.
Akumin, an Ontario company, through Delware registered Akumin Holdings Corp., controls and operates the US operations.
photo credit: 12019 via pixabay